Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2026-03-26 @ 3:20 PM
Ignite Modification Date:
2026-03-26 @ 3:20 PM
NCT ID:
NCT07482202
Eligibility Criteria:
Inclusion Criteria:
* 1\. Korean women aged 18 years or older who provided written informed consent to participate in the study
2\. Patients who underwent emergency or elective cesarean section
3\. Patients with a transverse skin and uterine incision (Pfannenstiel incision)
4\. Patients who received prophylactic antibiotics (Cefazolin 1g) intravenously 30 minutes prior to surgery
5\. Patients who completed at least three follow-up visits after discharge
Exclusion Criteria:
* Patients under 18 years of age
2\. Patients who did not undergo transverse skin or uterine incision (i.e., vertical incision)
3\. Use of antibiotics prior to delivery (excluding prophylactic antibiotics administered at delivery)
4\. Patients taking immunosuppressive drugs
5\. History of adhesive allergy or allergic skin diseases
6\. Patients unable to complete the required follow-up schedule
7\. Patients who did not consent or were unable to understand the study protocol
Healthy Volunteers:
False
Sex:
FEMALE
Minimum Age:
18 Years
Study:
NCT07482202
Study Brief:
Protocol Section:
NCT07482202